These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 17355999

  • 1. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
    Chan A, Iannucci A, Dager WE.
    Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The use of low-dose warfarin as prophylaxis for central venous catheter thrombosis in patients with cancer: a meta-analysis.
    Rawson KM, Newburn-Cook CV.
    Oncol Nurs Forum; 2007 Sep; 34(5):1037-43. PubMed ID: 17878131
    [Abstract] [Full Text] [Related]

  • 5. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients.
    Magagnoli M, Masci G, Castagna L, Pedicini V, Poretti D, Morenghi E, Brambilla G, Santoro A.
    Am J Hematol; 2006 Jan; 81(1):1-4. PubMed ID: 16369969
    [Abstract] [Full Text] [Related]

  • 6. Therapy Insight: venous-catheter-related thrombosis in cancer patients.
    Agnelli G, Verso M.
    Nat Clin Pract Oncol; 2006 Apr; 3(4):214-22. PubMed ID: 16596145
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer.
    Revel-Vilk S, Yacobovich J, Tamary H, Goldstein G, Nemet S, Weintraub M, Paltiel O, Kenet G.
    Cancer; 2010 Sep 01; 116(17):4197-205. PubMed ID: 20533566
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.
    Mismetti P, Mille D, Laporte S, Charlet V, Buchmüller-Cordier A, Jacquin JP, Fournel P, Dutrey-Dupagne C, Decousus H, CIP Study Group.
    Haematologica; 2003 Jan 01; 88(1):67-73. PubMed ID: 12551829
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thrombotic complications of central venous catheters in cancer patients.
    Kuter DJ.
    Oncologist; 2004 Jan 01; 9(2):207-16. PubMed ID: 15047925
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Venous thromboembolism in cystic fibrosis.
    Takemoto CM.
    Pediatr Pulmonol; 2012 Feb 01; 47(2):105-12. PubMed ID: 22006666
    [Abstract] [Full Text] [Related]

  • 20. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J, Goodin S.
    J Oncol Pharm Pract; 2007 Jun 01; 13(2):85-97. PubMed ID: 17873108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.